Health · India
Lupin Receives USFDA Tentative Approval for Prostate Cancer Drug
Indian pharmaceutical company Lupin has received tentative approval from the U.S. Food and Drug Administration (USFDA) for its Enzalutamide Tablets. This approval is for a drug used in the treatment of prostate cancer. The development marks a significant step for Lupin in the pharmaceutical market, particularly in the oncology segment.
How outlets across the spectrum covered it
Left 0 · Centre 2 · Right 0 n = 2
- Centre (2): Business Standard, Deccan Herald